Open prospective randomized controlled trials on efficacy of dapagliflozin and low carbohydrate diet on glycemic and lipid control

Trial Profile

Open prospective randomized controlled trials on efficacy of dapagliflozin and low carbohydrate diet on glycemic and lipid control

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Jan 2017 Acording to UMIN,the date for data entry closure is 2018/04/30 and the date for conclusion of data analysis is 2020/12/01.
    • 18 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 12 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top